AQR Capital Management
ALT icon

AQR Capital Management’s Altimmune ALT Stock Holding History

AQR Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
85,454
+64,307
+304% +$273K ﹤0.01% 3471
2025
Q4 		$76.3K Buy
+21,147
New +$92.2K ﹤0.01% 3480
2025
Q1 		– Sell
-12,577
Closed -$90.7K – 3151
2024
Q4 		$90.7K Sell
12,577
-11,308
-47% -$86.4K ﹤0.01% 2775
2024
Q3 		$147K Sell
23,885
-17,494
-42% -$119K ﹤0.01% 2618
2024
Q2 		$275K Sell
41,379
-19,315
-32% -$143K ﹤0.01% 2304
2024
Q1 		$618K Buy
+60,694
New +$617K ﹤0.01% 1878
2023
Q2 		– Sell
-21,662
Closed -$91.4K – 2184
2023
Q1 		$91.4K Buy
+21,662
New +$257K ﹤0.01% 2122

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AQR Capital Management's ALT Position: Q1 2026 in Review

AQR Capital Management increased its Altimmune (ALT) stake by 304% in Q1 2026, buying an estimated $273K and bringing the position to 85,454 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

AQR Capital Management first reported a position in ALT in Q1 2023 and has held it in 7 quarters since. The position peaked at $618K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • AQR Capital Management held 85,454 shares of Altimmune worth $263K as of Q1 2026.
  • AQR Capital Management bought 64,307 Altimmune shares in Q1 2026, an estimated $273K.
  • Altimmune made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3471 holding.
  • AQR Capital Management first reported a position in Altimmune in Q1 2023 and has held it in 7 quarters since.
  • AQR Capital Management's Altimmune position peaked at $618K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.